| Dr John Alonzo Luker, MD | |
|
4029 S Capital Of Texas Hwy, Suite 115, Austin, TX 78704-7927 | |
| (512) 326-1141 | |
| (512) 326-4444 |
| Full Name | Dr John Alonzo Luker |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 4029 S Capital Of Texas Hwy, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700890308 | NPI | - | NPPES |
| 122536902 | Medicaid | TX | |
| E2689 | Other | TX | PHYSICIAN'S PERMIT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | E2689 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Alonzo Luker, MD 4029 S Capital Of Texas Hwy, Suite 115, Austin, TX 78704-7927 Ph: (512) 326-1141 | Dr John Alonzo Luker, MD 4029 S Capital Of Texas Hwy, Suite 115, Austin, TX 78704-7927 Ph: (512) 326-1141 |
News Archive
An average of one in 100 children in the United States has an autism spectrum disorder according to the Centers for Disease Control and Prevention. While over the last few years an increasing number of these children have begun to receive early intervention services, research shows that high quality and intensive intervention are critical for positive outcomes.
Most cells can divide only a limited number of times and eventually undergo permanent cell cycle arrest, a state known as cellular senescence.
By coordinating with state health departments and communicating with each other about patients with C. difficile and antibiotic-resistant infections, hospitals, long-term acute-care facilities and nursing homes could reduce the number of such hospital-acquired infections (HAIs) by an estimated 619,000 cases in the next five years, a new Centers for Disease Control 9 (CDC)-led report has found.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
› Verified 2 days ago
Joseph Owens, MD General Practice Medicare: Medicare Enrolled Practice Location: 1400 N Ih 35 Ste 2.230, Austin, TX 78701 Phone: 512-324-8235 | |
Abel E Salazar Sr., MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 7610 W Hwy 71, F, Austin, TX 78735 Phone: 512-288-0859 | |
Dr. Brian Randall Riley, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 9333 Research Blvd Ste 400, Austin, TX 78759 Phone: 305-923-1144 | |
Molly T Campa, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 6811 Austin Center Blvd Ste 300, Austin, TX 78731 Phone: 214-820-6183 Fax: 512-406-7321 | |
Dr. Damon Vincent Borich, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1810 Kenwood Avenue, Austin, TX 78704 Phone: 512-441-8661 | |
Susan Callaway, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3828 S 1st St, Austin, TX 78704 Phone: 512-443-1311 Fax: 512-445-6457 | |
Dr. Edwin Tomas Melendez-murphy, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 6801 S Ih 35 Ste 1e, Austin, TX 78744 Phone: 512-978-9960 Fax: 512-776-0470 |